XTL Biopharmaceuticals Ltd.
XTLB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $371 | $1,401 | $2,094 | $2,969 |
| Short-Term Investments | $772 | $605 | $1,627 | $3,158 |
| Receivables | $99 | $29 | $71 | $94 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $98 | $11 | $14 | $16 |
| Total Curr. Assets | $1,340 | $2,046 | $3,806 | $6,237 |
| Property Plant & Equip (Net) | $187 | $0 | $0 | $1 |
| Goodwill | $3,193 | $0 | $0 | $0 |
| Intangibles | $3,816 | $380 | $380 | $380 |
| Long-Term Investments | $14 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $7,210 | $380 | $380 | $381 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,550 | $2,426 | $4,186 | $6,618 |
| Liabilities | – | – | – | – |
| Payables | $196 | $1 | $2 | $2 |
| Short-Term Debt | $138 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $18 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,855 | $205 | $185 | $229 |
| Total Curr. Liab. | $2,207 | $206 | $187 | $231 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $219 | $0 | $0 | $0 |
| Other NC Liab. | $689 | $0 | $0 | $1,054 |
| Total NC Liab. | $908 | $0 | $0 | $1,054 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,115 | $206 | $187 | $1,285 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $23,138 | $14,120 | $14,120 | $14,120 |
| Retained Earnings | -$159,009 | -$158,246 | -$156,467 | -$155,133 |
| AOCI | $20 | $20 | $20 | $20 |
| Other Equity | $141,286 | $146,326 | $146,326 | $146,326 |
| Total Equity | $5,435 | $2,220 | $3,999 | $5,333 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,550 | $2,426 | $4,186 | $6,618 |
| Net Debt | -$233 | -$1,401 | -$2,094 | -$2,969 |